The UK Says No to IDSA Lyme Guidelines

The submission states:

Despite the facts that Lyme disease is caused by at least two further genospecies of Borrelia burgdorferi sensu lato in Europe than in the USA and that there are clear differences in the resulting disease presentation, the IDSA guidelines are recommended for use within Europe and specifically within the UK by the UK Health Protection Agency (HPA). Lyme Disease Action believes that the IDSA guidelines should be presented with a clear delimitation of usage to the USA and a warning that other national authorities must conduct clinical trials and develop and publish independent guidelines specific to the conditions in their own regions.